{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:21:15Z","timestamp":1778397675019,"version":"3.51.4"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BMS\/TF\/Trans-Neuro\/2014-3368\/July-15\/20\/KA\/Govt"],"award-info":[{"award-number":["BMS\/TF\/Trans-Neuro\/2014-3368\/July-15\/20\/KA\/Govt"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jns.2018.08.032","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T17:56:49Z","timestamp":1535738209000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics"],"prefix":"10.1016","volume":"394","author":[{"given":"Palaniswamy","family":"Ramaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0024-4748","authenticated-orcid":false,"given":"Rita","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-9089","authenticated-orcid":false,"given":"Ravi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 Movement Disorders","key":"10.1016\/j.jns.2018.08.032_bb0005","first-page":"1189","article-title":"Parkinsonian syndromes","volume":"19","author":"Williams","year":"2013","journal-title":"Continuum (Minneapolis, Minn.)"},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20080295","article-title":"Protein stability and aggregation in Parkinson's disease","volume":"413","author":"Robinson","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jchemneu.2011.01.005","article-title":"MicroRNAs in Parkinson's disease","volume":"42","author":"Harraz","year":"2011","journal-title":"J. Chem. Neuroanat."},{"issue":"8","key":"10.1016\/j.jns.2018.08.032_bb0020","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0025","doi-asserted-by":"crossref","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"alpha-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0030","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson's disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson's disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2018.08.032_bb0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jnnp.2010.214890","article-title":"A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability","volume":"82","author":"Rolland","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7310","key":"10.1016\/j.jns.2018.08.032_bb0045","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/466S8a","article-title":"Parkinson's disease: a model dilemma","volume":"466","author":"Beal","year":"2010","journal-title":"Nature"},{"issue":"9192","key":"10.1016\/j.jns.2018.08.032_bb0050","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10048-016-0480-6","article-title":"microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP)","volume":"17","author":"Tatura","year":"2016","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jns.2018.08.032_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40673-014-0014-7","article-title":"An update on the cerebellar subtype of multiple system atrophy","volume":"1","author":"Ciolli","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.jns.2018.08.032_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","article-title":"Survival of patients with pathologically proven multiple system atrophy: a meta-analysis","volume":"48","author":"Ben-Shlomo","year":"1997","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.jns.2018.08.032_bb0075","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain J. Neurol."},{"issue":"37","key":"10.1016\/j.jns.2018.08.032_bb0080","doi-asserted-by":"crossref","first-page":"62703","DOI":"10.18632\/oncotarget.18697","article-title":"Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers","volume":"8","author":"Dou","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/dvdy.20572","article-title":"Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system","volume":"234","author":"Esquela-Kerscher","year":"2005","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jns.2018.08.032_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.acr.2017.06.006","article-title":"Animal Models to Study MicroRNA Function","volume":"135","author":"Pal","year":"2017","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0095","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/gb-2004-5-3-r13","article-title":"Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation","volume":"5","author":"Sempere","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.jns.2018.08.032_bb0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jns.2018.08.032_bb0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jns.2018.08.032_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physiolgenomics.00168.2010","article-title":"MicroRNA in central nervous system trauma and degenerative disorders","volume":"43","author":"Liu","year":"2011","journal-title":"Physiol. Genomics"},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/jcb.24004","article-title":"Control of mitochondrial activity by miRNAs","volume":"113","author":"Li","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jns.2018.08.032_bb0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/435745a","article-title":"Small RNAs with big impacts","volume":"435","author":"Meltzer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jns.2018.08.032_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2012.00082","article-title":"The path to microRNA therapeutics in psychiatric and neurodegenerative disorders","volume":"3","author":"Chan","year":"2012","journal-title":"Front. Genet."},{"issue":"5842","key":"10.1016\/j.jns.2018.08.032_bb0135","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science (New York, N.Y.)"},{"issue":"7306","key":"10.1016\/j.jns.2018.08.032_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature09191","article-title":"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression","volume":"466","author":"Gehrke","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jns.2018.08.032_bb0145","series-title":"Association of Variants in microRNA With Parkinson's Disease in Chinese Han Population","author":"Li","year":"2017"},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0150","first-page":"131","article-title":"Overexpression of miR185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK\/mTOR signaling pathway in Parkinson's disease","volume":"17","author":"Wen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jns.2018.08.032_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnmol.2017.00328","article-title":"Modulation of alpha-synuclein expression and associated effects by MicroRNA Let-7 in transgenic C. elegans","volume":"10","author":"Shamsuzzama","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.09.033","article-title":"Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease","volume":"365","author":"Lu","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3892\/mmr.2014.2837","article-title":"Bioinformatic analysis of microRNA expression in Parkinson's disease","volume":"11","author":"Hao","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.jns.2018.08.032_bb0170","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/emmm.201201900","article-title":"MicroRNA expression profile and functional analysis reveal that miR-382 is a critical novel gene of alcohol addiction","volume":"5","author":"Li","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0175","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","article-title":"miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling","volume":"35","author":"Kim","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"35","key":"10.1016\/j.jns.2018.08.032_bb0180","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jns.2018.08.032_bb0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fnagi.2017.00356","article-title":"Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: a Judicious Update","volume":"9","author":"Jan","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0190","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"2","author":"Thomas","year":"2007","journal-title":"Human Mol. Genet."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(03)00684-6","article-title":"Caught in the act: alpha-synuclein is the culprit in Parkinson's disease","volume":"40","author":"Eriksen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2018.08.032_bb0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2003.tb07465.x","article-title":"The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects","volume":"991","author":"Lim","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.58.2.179","article-title":"Recent advances in the genetics and pathogenesis of Parkinson disease","volume":"58","author":"Mouradian","year":"2002","journal-title":"Neurology"},{"issue":"5321","key":"10.1016\/j.jns.2018.08.032_bb0210","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0215","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.parkreldis.2015.03.011","article-title":"Parkinson disease: alpha-synuclein mutational screening and new clinical insight into the p.E46K mutation","volume":"21","author":"Pimentel","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","article-title":"Are Ubiquitination pathways central to Parkinson's disease?","volume":"114","author":"Giasson","year":"2003","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.03-0338rev","article-title":"Alpha-synuclein and Parkinson's disease","volume":"18","author":"Recchia","year":"2004","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1326-4-9","article-title":"\u03b1-Synuclein and neuronal cell death","volume":"4","author":"Cookson","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24066","article-title":"Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys","volume":"75","author":"Recasens","year":"2014","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2018.08.032_bb0240","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"issue":"5646","key":"10.1016\/j.jns.2018.08.032_bb0245","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science (New York, N.Y.)"},{"issue":"30","key":"10.1016\/j.jns.2018.08.032_bb0250","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of alpha-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0260","doi-asserted-by":"crossref","first-page":"E2079","DOI":"10.1002\/humu.21459","article-title":"SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes","volume":"32","author":"Mutez","year":"2011","journal-title":"Hum. Mutat."},{"issue":"16","key":"10.1016\/j.jns.2018.08.032_bb0265","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/mds.23313","article-title":"Clinical course of the first Asian family with Parkinsonism related to SNCA triplication","volume":"25","author":"Sekine","year":"2010","journal-title":"Movement Disord."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0270","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"issue":"49","key":"10.1016\/j.jns.2018.08.032_bb0275","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","article-title":"Role of alpha-synuclein in presynaptic dopamine recruitment","volume":"24","author":"Yavich","year":"2004","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pneurobio.2012.09.006","article-title":"Neurodegeneration as an RNA disorder","volume":"99","author":"Johnson","year":"2012","journal-title":"Prog. Neurobiol."},{"issue":"17","key":"10.1016\/j.jns.2018.08.032_bb0285","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0290","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12031-009-9325-1","article-title":"Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models","volume":"41","author":"Asikainen","year":"2010","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0295","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"31","key":"10.1016\/j.jns.2018.08.032_bb0300","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1073\/pnas.0906277106","article-title":"Repression of alpha-synuclein expression and toxicity by microRNA-7","volume":"106","author":"Junn","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2018.08.032_bb0305","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","article-title":"Manganese exposure: linking down-regulation of miRNA-7 and miRNA-433 with alpha-synuclein overexpression and risk of idiopathic Parkinson's disease","volume":"46","author":"Tarale","year":"2018","journal-title":"Toxicol. In Vitro"},{"issue":"17","key":"10.1016\/j.jns.2018.08.032_bb0310","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0315","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/prca.200780025","article-title":"MicroRNA and proteome expression profiling in early-symptomatic alpha-synuclein(A30P)-transgenic mice","volume":"2","author":"Gillardon","year":"2008","journal-title":"Proteomics Clin. Appl."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0320","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2010.03.076","article-title":"miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro","volume":"394","author":"Chen","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.jns.2018.08.032_bb0325","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M312497200","article-title":"Alpha-synuclein up-regulation and aggregation during MPP+\u2212induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide","volume":"279","author":"Kalivendi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0330","first-page":"993","article-title":"MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax and Sirt2","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"15","key":"10.1016\/j.jns.2018.08.032_bb0335","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Minones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.febslet.2014.12.014","article-title":"Inhibition of miR-34b and miR-34c enhances alpha-synuclein expression in Parkinson's disease","volume":"589","author":"Kabaria","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jns.2018.08.032_bb0345","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ncomms2032","article-title":"Alternative alpha-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology","volume":"3","author":"Rhinn","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2018.08.032_bb0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.parkreldis.2016.09.028","article-title":"Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus","volume":"33","author":"Tatura","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0355","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nsmb.1591","article-title":"Converging concepts of protein folding in vitro and in vivo","volume":"16","author":"Hartl","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0360","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-017-08324-z","article-title":"The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress alpha-synuclein aggregation","volume":"7","author":"Aprile","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bip.21302","article-title":"Hsp70 molecular chaperones and Parkinson's disease","volume":"93","author":"Witt","year":"2010","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molmed.2009.11.004","article-title":"Pathogenesis of Parkinson's disease: emerging role of molecular chaperones","volume":"16","author":"Bandopadhyay","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jns.2018.08.032_bb0375","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnins.2017.00185","article-title":"Protein quality control by molecular Chaperones in neurodegeneration","volume":"11","author":"Ciechanover","year":"2017","journal-title":"Front. Neurosci."},{"issue":"34","key":"10.1016\/j.jns.2018.08.032_bb0380","doi-asserted-by":"crossref","first-page":"29828","DOI":"10.1074\/jbc.M111.221796","article-title":"Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation","volume":"286","author":"Tranter","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0385","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.108.193250","article-title":"A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70","volume":"104","author":"Yin","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.jns.2018.08.032_bb0390","article-title":"miR-16-1 promotes the aberrant \u03b1-synuclein accumulation in Parkinson disease via targeting heat shock protein 70","volume":"2014","author":"Zhang","year":"2014","journal-title":"Sci. World J."},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0395","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0400","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/15548627.2017.1291114","article-title":"Defective retrograde transport impairs autophagic clearance in Alzheimer disease neurons","volume":"13","author":"Tammineni","year":"2017","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0405","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/EBC20170023","article-title":"Autophagy impairment in Parkinson's disease","volume":"61","author":"Karabiyik","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jns.2018.08.032_bb0410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnmol.2017.00311","article-title":"The neuroprotective role of protein quality control in halting the development of alpha-synuclein pathology","volume":"10","author":"Manecka","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-016-0292-9","article-title":"Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy","volume":"4","author":"Piras","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.jns.2018.08.032_bb0420","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4161\/auto.21488","article-title":"Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy","volume":"8","author":"Schaeffer","year":"2012","journal-title":"Autophagy"},{"issue":"Suppl. 4","key":"10.1016\/j.jns.2018.08.032_bb0425","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1353-8020(09)70830-2","article-title":"Does autophagy worsen or improve the survival of dopaminergic neurons?","volume":"15","author":"Pasquali","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"11","key":"10.1016\/j.jns.2018.08.032_bb0430","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/carcin\/bgs266","article-title":"MicroRNA regulation of autophagy","volume":"33","author":"Frankel","year":"2012","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0435","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1038\/cddis.2013.73","article-title":"Influence of microRNA deregulation on chaperone-mediated autophagy and \u03b1-synuclein pathology in Parkinson's disease","volume":"4","author":"Alvarez-Erviti","year":"2013","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0440","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4161\/auto.7.5.14811","article-title":"Systems biology of the autophagy-lysosomal pathway","volume":"7","author":"Jegga","year":"2011","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bpa.12267","article-title":"MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim","volume":"26","author":"Wang","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2018.08.032_bb0450","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0455","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5483\/BMBRep.2017.50.4.006","article-title":"microRNA-200a-3p enhances mitochondrial elongation by targeting mitochondrial fission factor","volume":"50","author":"Lee","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.jns.2018.08.032_bb0460","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41598-017-17878-x","article-title":"High content image analysis reveals function of miR-124 upstream of Vimentin in regulating motor neuron mitochondria","volume":"8","author":"Yardeni","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0465","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/JVI.02094-07","article-title":"Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction","volume":"82","author":"Kitayama","year":"2008","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020220","article-title":"Pre-microRNA and mature microRNA in human mitochondria","volume":"6","author":"Barrey","year":"2011","journal-title":"PLoS One"},{"issue":"7113","key":"10.1016\/j.jns.2018.08.032_bb0475","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0480","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1007\/s12035-017-0664-6","article-title":"Systemic Analysis of miRNAs in PD stress Condition: miR-5701 Modulates Mitochondrial\u2013Lysosomal Cross talk to Regulate Neuronal Death","volume":"55","author":"Prajapati","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0485","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-016-0121-4","article-title":"miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)","volume":"11","author":"Kim","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0490","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1152\/ajpendo.00073.2017","article-title":"MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes","volume":"313","author":"Li","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0495","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ejn.12444","article-title":"Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96","volume":"39","author":"Ubhi","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0500","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fncel.2014.00156","article-title":"Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy","volume":"8","author":"Vallelunga","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150705","article-title":"Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications","volume":"11","author":"Schafferer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2018.08.032_bb0510","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2016.10.034","article-title":"MicroRNA expression profiles of multiple system atrophy from formalin-fixed paraffin-embedded samples","volume":"635","author":"Wakabayashi","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0515","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mcn.2009.10.005","article-title":"An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling","volume":"43","author":"Impey","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0520","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","article-title":"MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy","volume":"10","author":"Valera","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0525","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.18632\/oncotarget.6732","article-title":"miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG","volume":"7","author":"Huangfu","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0530","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.3892\/mmr.2015.3215","article-title":"Inhibition of microRNA-101 attenuates hypoxia\/reoxygenationinduced apoptosis through induction of autophagy in H9c2 cardiomyocytes","volume":"11","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0535","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-3806(03)00056-7","article-title":"Isoforms changes of tau protein during development in various species","volume":"142","author":"Takuma","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"issue":"20","key":"10.1016\/j.jns.2018.08.032_bb0540","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","article-title":"MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy","volume":"20","author":"Smith","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0545","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2010.04.020","article-title":"Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach","volume":"39","author":"van Dijk","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2018.08.032_bb0550","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2016.00036","article-title":"microRNA Profiles in Parkinson's Disease Prefrontal Cortex","volume":"8","author":"Hoss","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2018.08.032_bb0555","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2017.09.039","article-title":"CSF biomarkers beta-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes","volume":"382","author":"Constantinides","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2018.08.032_bb0560","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","article-title":"MicroRNAs in Cerebrospinal Fluid as potential Biomarkers for Parkinson's Disease and Multiple System Atrophy","volume":"54","author":"Marques","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0565","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"20","key":"10.1016\/j.jns.2018.08.032_bb0570","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of microRNAs and microRNA-protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0575","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-8118-10-4","article-title":"Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells","volume":"10","author":"Haqqani","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"12","key":"10.1016\/j.jns.2018.08.032_bb0580","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0585","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd2310","article-title":"Interfering with disease: a progress report on siRNA-based therapeutics","volume":"6","author":"de Fougerolles","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jns.2018.08.032_bb0590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-3-19","article-title":"In vivo silencing of alpha-synuclein using naked siRNA","volume":"3","author":"Lewis","year":"2008","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0595","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.expneurol.2005.12.024","article-title":"Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi","volume":"198","author":"Sapru","year":"2006","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.jns.2018.08.032_bb0600","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jns.2018.08.032_bb0605","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jns.2018.08.032_bb0610","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","article-title":"MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson's disease","volume":"9","author":"Chen","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"R1","key":"10.1016\/j.jns.2018.08.032_bb0615","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0620","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jns.2018.08.032_bb0625","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neurobiolaging.2018.05.032","article-title":"MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients","volume":"69","author":"Tolosa","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0630","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2014.10.018","article-title":"miRNA expression is highly sensitive to a drug therapy in Parkinson's disease","volume":"21","author":"Alieva","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.08.032_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.26608","article-title":"Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease","author":"Liu","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.941","article-title":"Identification of aberrant circulating mi RNA s in Parkinson's disease plasma samples","volume":"8","author":"Chen","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.jns.2018.08.032_bb0645","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gene.2018.04.010","article-title":"Differential expression of miR-34a, miR-141, and miR-9 in MPP+\u2212treated differentiated PC12 cells as a model of Parkinson's disease","volume":"662","author":"Delavar","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.jns.2018.08.032_bb0650","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuro.2017.04.007","article-title":"Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: relevance to \u03b1-synuclein misfolding in metal neurotoxicity","volume":"64","author":"Harischandra","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jns.2018.08.032_bb0655","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0660","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","article-title":"Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression","volume":"38","author":"Li","year":"2017","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18632\/oncotarget.13905","article-title":"MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian","volume":"8","author":"Mo","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0670","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for Parkinson's disease","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.jns.2018.08.032_bb0675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2016.06.061","article-title":"Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum","volume":"629","author":"Nair","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.jns.2018.08.032_bb0680","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0685","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","article-title":"A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease","volume":"21","author":"Dong","year":"2016","journal-title":"Biomarkers"},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0690","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.24384","article-title":"Micro RNA association with synucleinopathy conversion in rapid eye movement behavior disorder","volume":"77","author":"Fern\u00e1ndez-Santiago","year":"2015","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0695","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.0000000000001258","article-title":"Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa\u2013treated patients with PD","volume":"84","author":"Serafin","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0700","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12031-014-0428-y","article-title":"MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects","volume":"54","author":"Cardo","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2018.08.032_bb0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094839","article-title":"Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology","volume":"9","author":"Burgos","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jns.2018.08.032_bb0710","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jnr.23377","article-title":"Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease","volume":"92","author":"Botta-Orfila","year":"2014","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.jns.2018.08.032_bb0715","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","article-title":"miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling","volume":"35","author":"Kim","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.jns.2018.08.032_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025443","article-title":"Convergence of miRNA expression profiling, \u03b1-synuclein interacton and GWAS in Parkinson's disease","volume":"6","author":"Martins","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0725","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jbiotec.2011.01.023","article-title":"Identification of blood microRNAs associated to Parkinso\u0144s disease","volume":"152","author":"Margis","year":"2011","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.jns.2018.08.032_bb0730","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12031-017-0926-9","article-title":"Plasma and white blood cells show different miRNA expression profiles in Parkinson's disease","volume":"62","author":"Schwienbacher","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0735","first-page":"852","article-title":"Serum microRNA expression profiling in patients with multiple system atrophy","volume":"17","author":"Kume","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.jns.2018.08.032_bb0740","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12035-014-8788-4","article-title":"Altered expression of miR-202 in cerebellum of multiple-system atrophy","volume":"51","author":"Lee","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"7068","key":"10.1016\/j.jns.2018.08.032_bb0745","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with 'antagomirs'","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jns.2018.08.032_bb0750","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/nar\/gkg185","article-title":"In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides","volume":"31","author":"Fluiter","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.jns.2018.08.032_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020098","article-title":"Sequence-specific inhibition of small RNA function","volume":"2","author":"Hutvagner","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jns.2018.08.032_bb0760","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2005.12.031","article-title":"LNA-modified oligonucleotides mediate specific inhibition of microRNA function","volume":"372","author":"Orom","year":"2006","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.jns.2018.08.032_bb0765","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18303538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T06:02:21Z","timestamp":1571810541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18303538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":153,"alternative-id":["S0022510X18303538"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.08.032","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}